Previous Article | Next Article 
Journal of Virology, June 1999, p. 5026-5033, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Trichostatin A Up-Regulates Human Papillomavirus
Type 11 Upstream Regulatory Region-E6 Promoter Activity in
Undifferentiated Primary Human Keratinocytes
Wei
Zhao,
Francisco
Noya,
Wen Yong
Chen,
Tim M.
Townes,
Louise T.
Chow, and
Thomas R.
Broker*
Department of Biochemistry and Molecular
Genetics, University of Alabama at Birmingham, Birmingham, Alabama
35294-0005
Received 20 October 1998/Accepted 10 March 1999
 |
ABSTRACT |
Human papillomavirus (HPV) gene expression in squamous epithelia is
differentiation dependent in benign patient lesions and in organotypic
raft cultures of primary human keratinocytes (PHKs). Using the
lacZ reporter in raft cultures, we previously showed that
this transcriptional regulation of the HPV type 11 (HPV-11) enhancer-promoter located in the upstream regulatory region (URR) appears to have resulted from coordination between the transcription transactivators AP1, Oct1, and Sp1 in differentiated upper strata and
the repressor C/EBP in proliferating basal cells. We report here that
trichostatin A, a specific inhibitor of histone deacetylase, dramatically stimulated reporter gene activity from the wild-type HPV-11 URR or the C/EBP mutation in PHKs grown in undifferentiated submerged cultures. In epithelial raft cultures, up-regulation occurred
predominantly in basal and parabasal strata; this effect was promoter
specific, as expression of the lacZ reporter gene driven by
the murine leukemia virus long terminal repeat (LTR), the keratin 14 promoter, or the involucrin promoter was not altered, nor was
expression of endogenous keratin 10 and profilaggrin affected. However,
the responses were not cell type or species specific, as identical
results were observed for both HPV-11 URR-lacZ and LTR-lacZ in murine retrovirus producer cell lines of
fibroblast origin.
 |
INTRODUCTION |
Human papillomaviruses (HPVs) infect
squamous epithelia at various body sites, causing warty lesions. The
low-risk HPV types, such as HPV type 6 (HPV-6) and HPV-11, cause
genital condylomata and recurrent respiratory papillomatoses that
almost never progress to high-grade lesions. On the other hand, the
high-risk HPV types HPV-16 and HPV-18 can cause neoplastic progression
in a low percentage of patients. In the productive infection program,
expression of HPV genes is differentiation dependent (12, 14,
27, 36, 37; reviewed in reference 11). The
HPV E7 protein inactivates the retinoblastoma susceptibility protein
(pRB), a tumor suppressor, thereby reactivating the host DNA
replication machinery in postmitotic, differentiated keratinocytes to
support vegetative viral DNA amplification (10). The E6
protein inactivates another tumor suppressor, p53, and is thought to
delay apoptosis, but this has not been directly tested. It is clear
that inappropriate expression of the E6 and E7 oncoproteins in stem
cells plays a major role in initiating viral carcinogenesis (reviewed
in references 11 and 20). Since no progeny viruses
are produced in high-grade dysplasias and carcinomas (36),
it is critical for the virus to maintain its differentiation-dependent transcription program.
We have developed an epithelial raft culture system and
demonstrated the squamous differentiation dependence of the
HPV-18 and HPV-11 enhancer-promoter located in the upstream
regulatory region (URR). In this system, the URR-driven reporter
is introduced into primary human keratinocytes (PHKs) via acute
infection with recombinant retroviruses. When the E7 gene is
used as a reporter, squamous differentiation of raft cultures is not
affected, but host DNA replication genes are reactivated and
unscheduled cellular DNA synthesis is induced in differentiated
keratinocytes (10). When the reporter is the bacterial
lacZ gene,
-galactosidase (
-Gal) activity is
predominantly detected in differentiated cell strata, with little or no
activity observed in basal cells. Interestingly, in proliferating PHKs
in submerged cultures, a significant fraction of the cells are positive
for reporter gene activity, indicating that active repression of the
URR occurs in basal proliferating cells upon stratification in raft
cultures (33, 47, 48). Site-directed mutagenesis of sequence
elements in both URRs has demonstrated that the integrity of the
transcription factor binding motifs Sp1, Oct1, and AP1 is critical for
conferring high
-Gal activities in differentiated keratinocytes.
Conversely, the presence of two C/EBP transcriptional factor binding
sites in the HPV11 URR diminishes reporter activity in the lower
strata, particularly in the basal layer, indicating that they mediate
URR repression.
Recent investigations have revealed that histone acetyltransferases and
deacetylases are integral constituents of eucaryotic transcription
complexes and that they participate critically in activating and
silencing promoter activities, respectively (for a review, see
reference 38). When histones H3 and H4 are
acetylated on lysine residues near their amino termini, reduced
positive charges lead to a relatively open chromatin conformation
conducive to transcription activation. Conversely, histone
deacetylation leads to a more condensed chromatin structure which is
relatively inactive in transcription. Specifically, transcription
coactivators such as p300, CBP, the nuclear receptor coactivator ACTR,
and TAF(II)250 possess histone acetyltransferase activities (3, 8,
29, 32, 39, 44), whereas certain transcription repressors function by recruiting histone deacetylases to target promoters. For
example, by collaborating with different factors, corepressor mSin3
inhibits Myc-responsive promoters as well as promoters targeted by
retinoic acid and thyroid hormone receptors (1, 2, 15, 18, 21,
30). The family of retinoblastoma proteins repress genes
necessary for cell cycle progression by binding to and inhibiting E2F
transcription factors and by recruiting histone deacetylases (6,
13, 23, 24).
Trichostatin A (TSA), a specific inhibitor of histone deacetylases, has
been used to assess a transcriptional regulatory role for promoter- or
locus-specific histone acetylation and deacetylation (45).
For example, TSA activates a reporter gene expressed from a
cytomegalovirus or human
-globin promoter which has been stably transduced into cell lines via an adenovirus-associated virus vector
(9). It also strongly induces the human immunodeficiency virus type 1 promoter reconstituted into chromatin in an in vitro transcription system (35). Interestingly, inhibitors of
histone deacetylases induce remission of promyelocytic leukemia by
activating transcription of retinoic acid receptor
-targeted genes
critical for maturation of haematopoietic cells. In these patients,
these genes are repressed by a fusion between the promyelocytic
leukemia zinc finger protein and retinoic acid receptor-
, generated
by chromosomal translocation (references 17 and
22 and references therein).
There has been no previous study of whether histone deacetylases
regulate papillomavirus promoters. Since mutations of C/EBP repressor
binding sites up-regulated URR promoter activity only in some basal
cells, C/EBP cannot entirely account for promoter repression in these
cells. We therefore examined the effect of TSA treatment on expression
of the HPV-11 URR-lacZ reporter in PHKs. We show that in
submerged, proliferating PHK cultures, TSA up-regulates reporter
expression from the wild type HPV-11 URR and a URR in which the one or
both of the known C/EBP repressor binding sites were mutated. In
stratified raft cultures, induction was observed predominantly in basal
and parabasal cells. These observations demonstrate that histone
deacetylases also contribute to the relative inactivity of the HPV
URR-E6 promoter in cells in the lower strata. Examination of raft
cultures for expression of the lacZ reporter from additional
viral or host promoters or for endogenous host proteins shows that this
up-regulation exerted by TSA is relatively promoter specific; however,
it is neither cell type nor species specific.
 |
MATERIALS AND METHODS |
Recombinant retroviral vectors.
The cloning vector
pLN-lacZ is derived from pLNSX (28), in which the
neomycin resistance gene is controlled by the murine leukemia virus
(MuLV) long terminal repeat (LTR) promoter; the simian virus 40 (SV40)
promoter has been removed so that the lacZ reporter is no
longer expressed, for lack of a dedicated promoter (33). In
pLN-11URR-lacZ, the wild-type or mutated URRs (spanning nucleotides 7072 to 7933, contiguous with nucleotides 1 to 99) were
placed in the correct orientation downstream of the neomycin resistance
gene to drive the lacZ reporter, as previously described (47). The C/EBP(distal [d]) and C/EBP(proximal [p])
elements were site-directed substitution mutations (48). The
C/EBPM(dp) double mutation was created by replacing the
BstEII and NdeI fragment from the C/EBP(d)
mutation with the same fragment containing a C/EBP(p) mutation.
pLN-K14-lacZ was similarly constructed by placing a 2.4-kb
human keratin 14 (K14) promoter (41) between the neomycin resistance gene and the reporter gene. In pLJ-lacZ, the
reporter gene is controlled by the MuLV LTR while the neomycin
resistance gene is directed by the SV40 promoter (33).
Production of retroviruses and acute infection of PHKs.
Ecotropic and amphotropic recombinant retroviruses were produced from
the helper cell line
-cre and pG+envAM12 (25), as previously described (33, 47). The latter producer cells
were grown in 10% bovine serum in Dulbecco's modified Eagle medium and selected with 800 µg of G418 (Geneticin; GIBCO/BRL) per ml for 6 days after infection with the ecotropic recombinant viruses. The cells
were used directly for the TSA induction study or were used to generate
amphotropic recombinant retroviruses. Amphotropic producer cells of
pBabe-inv-gal, in which the lacZ reporter driven by a 2.5-kb
involucrin promoter was inserted between the MuLV LTR and the SV40
promoter-driven puromycin resistance gene, were a generous gift of
Joseph Carroll and Lorne Taichman (16). First-passage PHK
cells at 30% confluence were infected with these recombinant retroviruses and then selected for 2 days with 400 µg of G418 per ml
or 1.5 µg of puromycin per ml in serum-free medium (GIBCO/BRL). All
uninfected cells died after selection. More than 50 to 70% of the
cells usually survived selection. These cells were used immediately for
experiments without further passage in order to minimize the
possibility of clonal selection of cells with transcriptional properties not characteristic of the bulk population. A fraction of the
keratinocytes was used for TSA induction studies in submerged cultures;
another fraction was used for developing raft cultures at the
air-medium interface.
TSA treatment.
Initial tests with a range of TSA (Sigma)
concentrations established the optimal concentration of 0.6 µM, at
which there was little or no toxicity while promoter induction was
evident. Toxicity was evaluated by cell morphology and cell viability
after removal of TSA (data not shown). The pG+envAM12 cell lines
transduced with wild-type HPV-11 URR-lacZ and
LTR-lacZ recombinant retroviruses were treated with 0.6 µM
TSA for 24 h. Retrovirus-infected and G418- or puromycin-selected
early passages of PHK cells were cultured in serum-free medium
(GIBCO/BRL) for 2-3 days in the absence of fibroblast feeders. The
cells were then treated with 0.6 µM TSA for 24 h. The treated
and untreated cells were stained with X-Gal (5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside), as
described before (47). Cells in duplicate plates were
trypsinized, lysed, and used for in vitro
-Gal enzymatic assays
(34). These experiments were performed twice with comparable results.
Epithelial raft cultures were developed on a dermal equivalent
consisting of a rat tail type I collagen matrix containing Swiss 3T3 J2
fibroblasts. After 9 days of culturing at the medium-air interface,
cultures were harvested and embedded in paraffin, as described
previously (47). Selected raft cultures were treated with
0.6 µM or higher concentrations of TSA on day 8 for 24 h. Five-micrometer sections of the raft cultures were cut for histologic analysis and detection of
-Gal-positive cells. The slides were photographed after a light counterstaining with hematoxylin and eosin
to correlate
-Gal activity with tissue morphology. Raft cultures
were prepared in duplicate, and each experiment was performed several
times with different batches of PHKs. Each batch was derived from
several neonatal foreskins.
Immunohistochemical assays.
Tissue sections were subjected
to antigen retrieval by heating in an 800-W microwave oven in 1%
ZnSO4 solution for 2 min at 30% power. A monoclonal
antibody for keratin 10 (Biogenex, San Ramon, Calif.) was used at a
1:50 dilution, and that for profilaggrin/filaggrin (Biomedical
Technologies, Stoughton, Mass.) was used at a 1:100 dilution.
Immunohistochemical staining by peroxidase was performed with a kit
from Zymed (San Francisco, Calif.).
 |
RESULTS |
We have previously shown that pLN-lacZ without a
dedicated promoter (Fig. 1C) did not
exhibit any
-Gal activity either in submerged, proliferating
cultures or in organotypic raft cultures of primary keratinocytes due
to an inefficient translation reinitiation of transcripts initiated
from the LTR after termination of the upstream neomycin resistance gene
product (33). pLJ-lacZ, in which the reporter is
driven by the MuLV LTR (Fig. 1A), is active in submerged cultures and
equally active in basal proliferating and differentiated spinous cells,
indicating that LTR promoter activity is not influenced by squamous
cell differentiation. In contrast, for pLN-URR-lacZ, in
which the reporter is preceded by the HPV-11 URR (Fig. 1D) or HPV-18
URR, the activities are observed in a fraction of submerged,
proliferating PHKs as well as in differentiated strata but not in the
basal proliferating layer of epithelial raft cultures. Based on these
observations and extensive mutagenesis of the URR, we have concluded
that, in the sequence context of pLN-URR-lacZ,
-Gal was
translated from transcripts initiated from the
differentiation-dependent URR but not from RNAs derived from the
upstream LTR (33, 47, 48). Using these constructs, we tested
the effects of TSA treatment. The activities of the different
reporters, however, should not be compared to one another, because
titers of the different recombinant viruses were not equalized in this
study.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
Retrovirus constructs. (A) pLJ-lacZ, in which
the lacZ reporter gene is directly driven by the MuLV LTR.
(B) pBabe-inv-gal, in which the lacZ gene is under the
control of a 2.5-kb involucrin promoter (16). (C)
pLN-lacZ, in which the reporter has no dedicated internal
promoter. (D) pLN-H11 URR-lacZ clone, in which the
lacZ reporter gene is driven by a wild-type or mutated
HPV-11 URR. (E) pLN-K14-lacZ, in which the reporter is
driven by a 2.4-kb human K14 promoter.
|
|
TSA up-regulates both the wild-type HPV-11 URR and the URR with
mutations in C/EBP transcription repressor binding sites in submerged,
proliferating PHKs.
We tested the effects of TSA treatment on
reporter activity in submerged, proliferating PHKs acutely infected
with the pLN-H11URR-lacZ retrovirus. After a 2-day selection
with G418, all uninfected cells died. Forty to 60% of infected PHKs
were positive for reporter activity in the absence of TSA. Upon TSA
treatment, more than 90% of the cells became positive, and the signal
intensity was also increased (Fig. 2A,
panels a and e). Upon treatment, PHKs assumed an enlarged and flattened
morphology. A morphological change has previously been noted for cell
lines (19). However, the effect was reversible upon removal
of TSA, and the cells resumed proliferation and could be passaged,
indicative of an absence of permanent toxicity (data not shown). To
ascertain that the effect of TSA was on the URR rather than on protein
translation in some unforeseen way, we tested in parallel experiments
pLN-lacZ, which lacks a dedicated promoter. It remained
completely negative with respect to
-Gal activity before and after
TSA treatment (Fig. 2A, panels d and h). These results demonstrate that
the HPV-11 URR is down-regulated by histone deacetylases in submerged proliferating keratinocytes. To investigate whether histone
deacetylases are recruited to the URR by the C/EBP family of proteins
bound to the two previously characterized sites, we tested the TSA
responsiveness of mutations in which the distal site (d) or both the
distal and proximal sites (dp) have been mutated. TSA stimulated the
reporter activities in both cases, as it did for wild-type HPV-11
URR-lacZ (Fig. 2A, panels b and f, and data not shown).

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 2.
-Gal activities upon TSA induction of
retrovirus-transduced cells in submerged, proliferating cultures. (A)
Retrovirus-transduced PHKs. (B) pG+envAM12 retroviral producer cells.
Panels a to d show cultures not treated with TSA. Panels e to h show
cultures induced with 0.6 µM TSA for 24 h immediately prior to
-Gal assays. a and e, pLN-H11URR-lacZ; b and f,
pLN-11-URR-C/EBP(d)M-lacZ; c and g, pLJ-lacZ; d
and h, pLN-lacZ.
|
|
To quantify the overall extent of up-regulation, in vitro

-Gal
assays of cell lysates were performed and the average induction
from
two independent experiments was determined (Table
1). The
results show that TSA stimulated
wild-type URR-
lacZ by 3.4-fold,
the C/EBPM(d) mutation by
3.7-fold, and the C/EBPM(dp) double
mutation by 4.1-fold. These levels
of induction are consistent
with the visual impression that both the
number of positive cells
and signal strengths were elevated in
TSA-treated cells. In contrast,
pLN-
lacZ-transduced PHKs did
not exhibit any

-Gal activity with
or without TSA treatment,
relative to uninfected cells. These
results support the notion that
histone deacetylases can repress
the HPV-11 URR independent of the two
C/EBP binding sites.
TSA stimulates wild-type and mutated HPV-11 URRs in PHK raft
cultures.
To assess the effects of TSA on the HPV-11 URR during
squamous differentiation, we prepared organotypic cultures of PHKs
infected with recombinant retroviruses. Cultures were treated on the
8th day with 0.6 µM (Fig. 3) to 3 µM
TSA (data not shown) and harvested after 24 h. As reported
previously for untreated cultures, reporter gene activity was
essentially restricted to suprabasal, differentiated cells. Upon TSA
treatment,
-Gal reporter gene activity was dramatically induced in
the lower strata, especially in undifferentiated basal cells. There was
only a rather moderate effect in the differentiated upper layers
(compare Fig. 3a and b). As described previously (48), the
reporter activity from pLN-H11URR-C/EBPM(d) was up-regulated, mainly in
the basal stratum (compare Fig. 3c and a). TSA significantly increased
the number of strongly positive cells in the lower strata (compare Fig.
3c and d). Raft cultures infected with pLN-lacZ had no
reporter activity in the presence or absence of TSA (Fig. 3g and h).
Thus, we conclude that histone deacetylases contribute to the low-level
activity of the HPV URR in cells in the lower strata.

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 3.
-Gal activities upon TSA induction of PHKs in raft
cultures. TSA was added on the 8th day to a concentration of 0.6 µM
to one of duplicate cultures, and rafts were harvested on the 9th day.
Cultures were fixed and stained for -Gal activity in situ. Panels a,
c, e, g, and i show cultures not treated with TSA, whereas panels b, d,
f, h, and j show cultures treated with TSA. a and b,
HPV-11-URR-lacZ; c and d, HPV-11 C/EBP(d)M-lacZ;
e and f, pLJ-lacZ; g and h, pLN-lacZ; i and j,
pBabe-inv-gal.
|
|
The up-regulation of reporter activity by TSA is promoter
specific.
To rule out that TSA might up-regulate viral or host
genes nondiscriminatively, we examined the response of the
lacZ reporter controlled by other promoters in PHKs grown in
submerged and raft cultures. First, we examined PHKs transduced with
pLJ-lacZ, in which the LTR controls reporter gene
expression.
-Gal activity was observed in a population of submerged
PHKs (Fig. 2A, panel c) and in some of the basal and differentiated
keratinocytes in raft cultures in the absence of TSA (Fig. 3e), in
agreement with our previous observation (33). Upon exposure
to TSA over a range of concentrations from 0.6 to 3 µM, we detected
no discernable induction in either submerged or raft cultures (Fig. 2A,
panel g, and Fig. 3f; also data not shown).
We then examined PHKs similarly transduced with recombinant
retroviruses in which the
lacZ reporter was driven by the
promoter
of the basal-cell-specific human K14 (
41) or that
of the differentiated
squamous-cell-specific involucrin (
7),
previously characterized
in transgenic mice. In submerged PHKs
transduced with pLN-K14-
lacZ (Fig.
1E) or pBabe-inv-gal
(Fig.
1B), 30 to 40% of cells were
positive for

-Gal activity. TSA
treatment doubled the percentage
of positive cells.

-Gal assay of
the respective cell lysates
indicated a six- or twofold activity in
these cultures relative
to untreated cultures (Table
1). Interestingly,
we rarely detected
involucrin by immunofluorescence in untreated PHKs
in submerged
cultures (
47). We do not know whether this
discrepancy between
reporter expression and endogenous gene product is
due to a difference
in sensitivity of the two assays or to
posttranscriptional regulation
of involucrin
messages.
In raft cultures,

-Gal activity in
pLN-K14-
lacZ-transduced cells was confined to basal and
lower spinous cells (data not
shown). This observation is in agreement
with the distribution
of endogenous K14 mRNA in raft cultures, as the
control of transcription
shutoff or mRNA turnover upon differentiation
in vitro is less
stringent than in vivo (
40). Conversely, in
pBabe-inv-gal-transduced
cultures, reporter activity was confined to
the upper spinous
cells (Fig.
3i). The presence of TSA at a 0.6 µM or
higher concentration
did not alter the distribution or intensity of
reporter gene expression
in either culture (Fig.
3j and data not
shown). These results
strongly suggest that promoter regulation by
histone deacetylation
has a certain degree of
specificity.
We also examined the expression of two endogenous cellular genes,
keratin 10 and profilaggrin, by immunohistochemistry in
duplicate raft
cultures that were transduced with pLN-H11URR-
lacZ or
the C/EBP(d) mutation but not stained for

-Gal activities.
Keratin
10 is normally detected only in spinous cells and in granulocytes
in
cutaneous squamous epithelia, whereas profilaggrin is a marker
for
terminal squamous differentiation and is synonymous with keratohyalin
granules in granulocytes in the more superficial layers. The pattern
of
expression of neither host gene was altered by TSA (Fig.
4,
compare panels a to b and c to d; also
data not shown). Notably,
these two genes were not induced in the lower
strata, where TSA
significantly up-regulated HPV-11
URR-
lacZ. While it is possible
that the sensitivity of this
assay may not be as high as that
of the

-Gal assay, these
observations agree with the notion that
histone deacetylases do not
regulate all promoters.

View larger version (86K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of cellular protein in raft cultures as
revealed by immunohistochemistry. A pLN-H11
URR-lacZ-transduced PHK raft culture treated with 0.6 µM
TSA for 24 h (b and d) or an untreated control culture (a and c)
(duplicate cultures of those shown in Fig. 3 that were not stained for
-Gal) was probed with a monoclonal antibody against keratin 10 (a
and b) or profilaggrin (c and d).
|
|
Promoter responses to TSA induction are not cell type
specific.
To examine whether the response of a given promoter to
TSA is cell type specific, we examined reporter activities in the
pG+envAM12 producer cells of four recombinant retroviruses:
pLN-lacZ, pLJ-lacZ, and
pLN-H11URR-lacZ and the C/EBP(d) mutation. The producer
cells are derived from mouse 3T3 fibroblasts. As in PHKs,
pLN-lacZ exhibited no
-Gal activity in the presence or
absence of TSA (Fig. 2B, panels d and h). Not surprisingly,
LTR-lacZ had relatively high-level activity, but there was
no detectable induction by TSA at concentrations up to 3 µM (Fig. 2B,
panels c and g). The reporter activity from the wild-type URR (Fig. 2B,
panels a and e) and from the C/EBP(d) mutation (Fig. 2B, panels b and
f) were both strongly stimulated when treated with TSA. In vitro
-Gal assays confirmed this qualitative visual evaluation.
pLN-H11URR-lacZ was stimulated by 7.2-fold relative to
untreated cultures, whereas neither pLN-lacZ nor
pLJ-lacZ was affected (Table 1).
 |
DISCUSSION |
Multiple mechanisms control squamous cell differentiation-dependent
up-regulation of the HPV-11 URR-E6 promoter.
Previous studies from
our laboratory and others have revealed that expression of the HPV E6
and E7 genes is differentiation dependent in benign lesions from
patients (11). We have recapitulated this
differentiation-dependent URR activity in organotypic cultures of PHKs
that were acutely transduced with recombinant retrovirus carrying an
HPV-18 or HPV-11 URR-driven lacZ reporter (33, 47, 48). Site-directed mutagenesis of the URR in this system
demonstrated that two mechanisms contribute to this promoter
regulation. For both HPV-18 and HPV-11, binding to the
enhancer-promoter elements of transcription activators such as Sp1,
AP1, and Oct1 confers high-level activity in differentiated spinous
cells. For HPV-11, the second form of regulation is transcription
repression by a member or members of the C/EBP family in the lower
strata, especially in the basal cells. The present study has shown for
the first time that the state of histone deacetylation appears to
comprise a third mechanism, as TSA, a specific inhibitor of histone
deactylases, dramatically up-regulated both the wild-type URR and C/EBP
mutations. Collectively, these three mechanisms lead to squamous cell
differentiation-dependent promoter activity.
What might be the host transcriptional factor or factors that recruit
histone deacetylases to the HPV-11 URR? Because mutations
in one or
both C/EBP binding sites in the HPV-11 URR maintain
responsiveness to
TSA treatment (Fig.
2 and
3; Table
1), C/EBP
bound to these two sites
would not appear to be responsible. However,
the possibility of
additional, yet-to-be-identified C/EBP sites
cannot be ruled out.
Alternatively, transcription factors bound
to other sites may be
responsible for recruiting histone deacetylases.
One candidate factor
is YY1, which interacts with mammalian histone
deacetylases, and the
ability of YY1 to repress transcription
requires these interactions
(
42,
43). Although YY1 binding
sites have not been reported
in the HPV-11 URR, multiple YY1 sites
in HPV-16 or HPV-18 URR modulate
their respective E6 promoter
activities in cell lines (
4,
5,
26,
31). In HPV-18,
YY1 interacts with C/EBP

to enhance promoter
activity. When the
C/EBP

binding site is deleted, YY1 becomes a
repressor in a cell-type-specific
manner. The detailed mechanism is not
understood, nor has regulation
by YY1 been reported in PHKs.
Nevertheless, it is conceivable
that YY1 also mediates histone
deacetylase repression of the HPV-11
URR. A 5' deletion mutation, 24-N,
which retains nucleotides 7674
to 7933/1 to 99 but no longer contains
the distal C/EBP site was
also responsive to TSA stimulation (our
unpublished results).
This observation narrows the URR sequences to
which these factors
can bind and recruit histone deacetylases to a
350-bp segment
upstream from the RNA initiation site at nucleotide
position 99.
During squamous differentiation, these host proteins
either are
no longer present, are not able to bind to the URR due to
competition
by other transcription factors, or are counteracted by
other host
proteins that recruit histone
acetyltransferases.
Regulation by histone deacetylases is promoter specific but not
cell type specific.
Our results with PHKs and amphotropic
fibroblast producer cells demonstrate that promoter regulation by
histone deacetylation is not cell type specific, as identical results
were observed for the wild-type HPV-11 URR and for the LTR despite the
different strengths of these two promoters in the two cell types (Fig.
2 and Table 1). Thus, histone deacetylase recruiting factors present in
mouse fibroblasts are similar to those in PHKs. However, this regulation appears to be promoter specific in raft cultures. Of the
four lacZ reporters tested, only the HPV-11 URR-E6 promoter was stimulated by TSA treatment, whereas the MuLV LTR promoter, which
is active in all cell strata; the K14 promoter, which is restricted to
less-differentiated PHKs; and the involucrin promoter, which is
confined to more differentiated strata, were not altered (Fig. 3).
Moreover, expression of the endogenous differentiation-dependent keratin 10 and profilaggrin proteins was not affected (Fig. 4). Collectively, these results rule out the possibility that TSA alters
the transcriptional milieu of host cells in a dramatic, universal
fashion, leading to a nonspecific promoter deregulation. We also infer
that the squamous cell differentiation-dependent up-regulation of
keratin 10, involucrin, and profilaggrin is mediated through mechanisms
not identical to those responsible for that of the HPV-11 URR.
Interestingly, in proliferating submerged cultures, all but the MuLV
LTR were up-regulated by TSA. These results further highlight the
differences in properties between proliferating cells in submerged
cultures and those in the basal layer of a squamous epithelium. The
absence of a response by pLN-lacZ without a dedicated
promoter also shows that TSA does not have a discernable effect on mRNA
translation. Lastly, the findings in this study further reinforce our
previous interpretation that the URR, not the LTR, drives expression of
the reporter in our HPV URR-based retroviral transduction system.
It is interesting to note that in submerged, proliferating cultures,
only a fraction of cells were positive for

-Gal activity
(Fig.
2).
We do not believe that heterogeneity in transgene expression
is related
to cell cycle. First, TSA arrests cells in G
1 or
G
2 phase (
19,
46). Thus, it is unlikely that
cells positive for

-Gal in the absence of TSA are in S phase when
the chromatin
could be relatively more open in newly replicated DNA
prior to
histone deacetylation. Second, heterogeneous expression of the
lacZ reporter was observed with all four promoters
regardless
of whether they responded to TSA in submerged cultures
(Table
1 and Fig.
2) or of their pattern of expression in raft cultures
in the presence or absence of TSA (Fig.
3). These observations
would be
difficult to reconcile with the hypothesis that expression
is cell
cycle regulated. We suggest several more-probable explanations
that are
not mutually exclusive. First, since bulk cultures rather
than clonal
cell lines were examined, the sites of proviral integration
undoubtedly
varied in the infected cell population. Consequently,
the
transcriptional environment of the integrated proviruses could
vary
from site to site. Second, the copy number of proviruses
in infected
cells varies according to a Poisson distribution.
These two factors can
affect the levels of reporter transcripts.
Third, because

-Gal is a
tetrameric enzyme, the protein concentration
may not reach the
threshold to reveal enzymatic activity in some
cells when the provirus
copy number is low or when the transcriptional
environment is less than
optimal.
The observation that the HPVs contain multiple
cis elements
in the URR to down-regulate its enhancer-E6 promoter in basal
and
parabasal cells emphasizes that it is crucial for the virus
to minimize
E6 and E7 gene expression in these cells during productive
infection.
The adverse consequence of constitutive expression
of the high-risk HPV
E6 and E7 proteins in proliferating cells
is evident; in vivo and in
vitro, it dysregulates cell growth
and differentiation, causing
dysplasias and carcinomas, conditions
not conducive to virus
propagation.
 |
ACKNOWLEDGMENTS |
This research was supported by USPHS grants CA 36200 and DE/CA
11910. Wei Zhao was a recipient of NIAID predoctoral training grant AI07150.
We thank Jeffrey E. Kudlow for providing the K14 promoter and Joseph M. Carroll and Lorne B. Taichman for pBabe-inv-gal amphotropic producer
cells. We also thank Ge Jin for embedding and sectioning of raft
cultures and the nurses of Cooper Green Hospital of Birmingham for
collecting neonatal foreskins.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Genetics, University of Alabama at
Birmingham, Birmingham, AL 35294-0005. Phone: (205) 975-8200. Fax:
(205) 975-6075. E-mail: broker{at}uab.edu.
 |
REFERENCES |
| 1.
|
Alland, L.,
R. Muhle,
H. J. Hou,
J. Potes,
L. Chin,
A. N. Schreiber, and R. A. DePinho.
1997.
Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression.
Nature
387:49-55[Medline].
|
| 2.
|
Ayer, D. E.,
Q. A. Lawrence, and R. N. Eisenman.
1995.
Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.
Cell
80:767-776[Medline].
|
| 3.
|
Bannister, A. J., and T. Kouzarides.
1996.
The CBP co-activator is a histone acetyltransferase.
Nature
384:641-643[Medline].
|
| 4.
|
Bauknecht, T.,
R. H. See, and Y. Shi.
1996.
A novel C/EBP -YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region.
J. Virol.
70:7695-7705[Abstract].
|
| 5.
|
Bauknecht, T., and Y. Shi.
1998.
Overexpression of C/EBP represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein.
J. Virol.
72:2113-2124[Abstract/Free Full Text].
|
| 6.
|
Brehm, A.,
E. A. Miska,
D. J. McCance,
J. L. Reid,
A. J. Bannister, and T. Kouzarides.
1998.
Retinoblastoma protein recruits histone deacetylase to repress transcription.
Nature
391:597-601[Medline].
|
| 7.
|
Carroll, J. M.,
K. M. Albers,
J. A. Garlick,
R. Harrington, and L. B. Taichman.
1993.
Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice.
Proc. Natl. Acad. Sci. USA
90:10270-10274[Abstract/Free Full Text].
|
| 8.
|
Chen, H.,
R. J. Lin,
R. L. Schiltz,
D. Chakravarti,
A. Nash,
L. Nagy,
M. L. Privalsky,
Y. Nakatani, and R. M. Evans.
1997.
Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.
Cell
90:569-580[Medline].
|
| 9.
|
Chen, W. Y.,
E. C. Bailey,
S. L. McCune,
J. Y. Dong, and T. M. Townes.
1997.
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.
Proc. Natl. Acad. Sci. USA
94:5798-5803[Abstract/Free Full Text].
|
| 10.
|
Cheng, S.,
D.-C. Schmidt-Grimminger,
T. Murant,
T. R. Broker, and L. T. Chow.
1995.
Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.
Genes Dev.
9:2335-2349[Abstract/Free Full Text].
|
| 11.
|
Chow, L. T., and T. R. Broker.
1997.
Small DNA tumor viruses, p. 267-301.
In
N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 12.
|
Dollard, S. C.,
J. L. Wilson,
L. M. Demeter,
W. Bonnez,
R. C. Reichman,
T. R. Broker, and L. T. Chow.
1992.
Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures.
Genes Dev.
6:1131-1142[Abstract/Free Full Text].
|
| 13.
|
Ferreira, R.,
L. Magnaghi-Jaulin,
P. Robin,
A. Harel-Bellan, and D. Trouche.
1998.
The three members of the pocket protein family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Proc. Natl. Acad. Sci. USA
95:10493-10498[Abstract/Free Full Text].
|
| 14.
|
Frattini, M. G.,
H. B. Lim,
J. Doorbar, and L. A. Laimins.
1997.
Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates.
J. Virol.
71:7068-7072[Abstract].
|
| 15.
|
Garcia, V. P.,
L. A. Jimenez,
A. I. Castillo, and A. Aranda.
1997.
Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression.
DNA Cell Biol.
16:421-431[Medline].
|
| 16.
|
Ghazizadeh, S.,
J. M. Carroll, and L. B. Taichman.
1997.
Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy.
J. Virol.
71:9163-9169[Abstract].
|
| 17.
|
Grignani, F.,
S. De Matteis,
C. Nervi,
L. Tomassoni,
V. Gelmetti,
M. Cioce,
M. Fanelli,
M. Ruthardt,
F. F. Ferrara,
I. Zamir,
C. Seiser,
F. Grignani,
M. A. Lazar,
S. Minucci, and P. G. Pelicci.
1998.
Fusion proteins of the retinoic acid receptor- recruit histone deacetylase in promyelocytic leukaemia.
Nature
391:815-818[Medline].
|
| 18.
|
Hassig, C. A.,
T. C. Fleischer,
A. N. Billin,
S. L. Schreiber, and D. E. Ayer.
1997.
Histone deacetylase activity is required for full transcriptional repression by mSin3A.
Cell
89:341-347[Medline].
|
| 19.
|
Hoshikawa, Y.,
H. J. Kwon,
M. Yoshida,
S. Horinouchi, and T. Beppu.
1994.
Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines.
Exp. Cell Res.
214:189-197[Medline].
|
| 20.
|
Jones, D. L., and K. Münger.
1996.
Interactions of the human papillomavirus E7 protein with cell cycle regulators.
Semin. Cancer Biol.
7:327-337[Medline].
|
| 21.
|
Laherty, C. D.,
W. M. Yang,
J. M. Sun,
J. R. Davie,
E. Seto, and R. N. Eisenman.
1997.
Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.
Cell
89:349-356[Medline].
|
| 22.
|
Lin, R. J.,
L. Nagy,
S. Inoue,
W. Shao,
W. J. Miller, and R. M. Evans.
1998.
Role of histone deacetylase complex in acute promyelocytic leukaemia.
Nature
391:811-814[Medline].
|
| 23.
|
Luo, R. X.,
A. A. Postigo, and D. C. Dean.
1998.
Rb interacts with histone deacetylase to repress transcription.
Cell
92:463-473[Medline].
|
| 24.
|
Magnaghi-Jaulin, L.,
R. Groisman,
I. Naguilbneva,
P. Robin,
S. Lorain,
J. Le Villain,
F. Troalent,
D. Trouche, and A. Harel-Bellan.
1998.
Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
Nature
395:601-605.
|
| 25.
|
Markowitz, D.,
S. Goff, and A. Bank.
1988.
Construction and use of a safe and efficient amphotropic packaging cell line.
Virology
167:400-406[Medline].
|
| 26.
|
May, M.,
X. P. Dong,
E. Beyer-Finkler,
F. Stubenrauch,
P. G. Fuchs, and H. Pfister.
1994.
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
EMBO J.
13:1460-1466[Medline].
|
| 27.
|
Meyers, C.,
T. J. Mayer, and M. A. Ozbun.
1997.
Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.
J. Virol.
71:7381-7386[Abstract].
|
| 28.
|
Miller, A. D., and G. J. Rosman.
1989.
Improved retroviral vectors for gene transfer and expression.
BioTechniques
7:980-982[Medline].
|
| 29.
|
Mizzen, C. A.,
X. J. Yang,
T. Kokubo,
J. E. Brownell,
A. J. Bannister,
H. T. Owen,
J. Workman,
L. Wang,
S. L. Berger,
T. Kouzarides,
Y. Nakatani, and C. D. Allis.
1996.
The TAF(II)250 subunit of TFIID has histone acetyltransferase activity.
Cell
87:1261-1270[Medline].
|
| 30.
|
Nagy, L.,
H. Y. Kao,
D. Chakravarti,
R. J. Lin,
C. A. Hassig,
D. E. Ayer,
S. L. Schreiber, and R. M. Evans.
1997.
Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.
Cell
89:373-380[Medline].
|
| 31.
|
O'Connor, M. J.,
S. H. Tan,
C. H. Tan, and H.-U. Bernard.
1996.
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity.
J. Virol.
70:6529-6539[Abstract/Free Full Text].
|
| 32.
|
Ogryzko, V. V.,
R. L. Schiltz,
V. Russanova,
B. H. Howard, and Y. Nakatani.
1996.
The transcriptional coactivators p300 and CBP are histone acetyltransferases.
Cell
87:953-959[Medline].
|
| 33.
|
Parker, J. N.,
W. Zhao,
K. J. Askins,
T. R. Broker, and L. T. Chow.
1997.
Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes.
Cell Growth Differ.
8:751-762[Abstract].
|
| 34.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed., vol. 3. , p. 16.66-16.67.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 35.
|
Sheridan, P. L.,
T. P. Mayall,
E. Verdin, and K. A. Jones.
1997.
Histone acetyltransferases regulate HIV-1 enhancer activity in vitro.
Genes Dev.
11:3327-3340[Abstract/Free Full Text].
|
| 36.
|
Stoler, M. H.,
C. R. Rhodes,
A. Whitbeck,
S. M. Wolinsky,
L. T. Chow, and T. R. Broker.
1992.
Gene expression of human papillomavirus type 16 and 18 in cervical neoplasias.
Hum. Pathol.
23:117-128[Medline].
|
| 37.
|
Stoler, M. H.,
S. M. Wolinsky,
A. Whitbeck,
T. R. Broker, and L. T. Chow.
1989.
Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.
Virology
172:331-340[Medline].
|
| 38.
|
Struhl, K.
1998.
Histone acetylation and transcriptional regulatory mechanisms.
Genes Dev.
12:599-606[Free Full Text].
|
| 39.
|
Wang, L.,
C. Mizzen,
C. Ying,
R. Candau,
N. Barlev,
J. Brownell,
C. D. Allis, and S. L. Berger.
1997.
Histone acetyltransferase activity is conserved between yeast and human GCN5 and is required for complementation of growth and transcriptional activation.
Mol. Cell. Biol.
17:519-527[Abstract].
|
| 40.
|
Wilson, J. L.,
S. C. Dollard,
L. T. Chow, and T. R. Broker.
1992.
Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures.
Cell Growth Differ.
3:471-483[Abstract].
|
| 41.
|
Xie, W.,
X. Wu,
L. T. Chow,
E. Chin,
A. J. Paterson, and J. E. Kudlow.
1998.
Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
Cell Growth Differ.
9:313-325[Abstract].
|
| 42.
|
Yang, W.-M.,
C. Inouye,
Y.-Y. Zeng,
D. Bearss, and E. Seto.
1996.
Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3.
Proc. Natl. Acad. Sci. USA
93:12845-12850[Abstract/Free Full Text].
|
| 43.
|
Yang, W.-M.,
Y.-L. Yao,
J.-M. Sun,
J. R. Davie, and E. Seto.
1997.
Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family.
J. Biol. Chem.
272:28001-28007[Abstract/Free Full Text].
|
| 44.
|
Yang, X. J.,
V. V. Ogryzko,
J. Nishikawa,
B. H. Howard, and Y. Nakatani.
1996.
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
Nature
382:319-324[Medline].
|
| 45.
|
Yoshida, M.,
S. Horinouchi, and T. Beppu.
1995.
Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function.
Bioessays
17:423-430[Medline].
|
| 46.
|
Yoshida, M.,
M. Kijima,
M. Akita, and T. Beppu.
1990.
Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.
J. Biol. Chem.
265:17174-17179[Abstract/Free Full Text].
|
| 47.
|
Zhao, W.,
L. T. Chow, and T. R. Broker.
1997.
Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.
J. Virol.
71:8832-8840[Abstract].
|
| 48.
|
Zhao, W.,
L. T. Chow, and T. R. Broker.
1998.
A distal element in the HPV-11 upstream regulatory region contributes to promoter repression in basal keratinocytes in squamous epithelium.
Virology
253:219-229.
|
Journal of Virology, June 1999, p. 5026-5033, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Banerjee, N. S., Genovese, N. J., Noya, F., Chien, W.-M., Broker, T. R., Chow, L. T.
(2006). Conditionally activated e7 proteins of high-risk and low-risk human papillomaviruses induce s phase in postmitotic, differentiated human keratinocytes.. J. Virol.
80: 6517-6524
[Abstract]
[Full Text]
-
Van Tine, B. A., Kappes, J. C., Banerjee, N. S., Knops, J., Lai, L., Steenbergen, R. D. M., Meijer, C. L. J. M., Snijders, P. J. F., Chatis, P., Broker, T. R., Moen, P. T. Jr., Chow, L. T.
(2004). Clonal Selection for Transcriptionally Active Viral Oncogenes during Progression to Cancer. J. Virol.
78: 11172-11186
[Abstract]
[Full Text]
-
Noya, F., Balague, C., Banerjee, N. S., Curiel, D. T., Broker, T. R., Chow, L. T.
(2003). Activation of Adenovirus Early Promoters and Lytic Phase in Differentiated Strata of Organotypic Cultures of Human Keratinocytes. J. Virol.
77: 6533-6540
[Abstract]
[Full Text]
-
Noya, F., Chien, W.-M., Wu, X., Banerjee, N. S., Kappes, J. C., Broker, T. R., Chow, L. T.
(2002). The Promoter of the Human Proliferating Cell Nuclear Antigen Gene Is Not Sufficient for Cell Cycle-dependent Regulation in Organotypic Cultures of Keratinocytes. J. Biol. Chem.
277: 17271-17280
[Abstract]
[Full Text]
-
Pena, L. d. M., Laimins, L. A.
(2001). Differentiation-Dependent Chromatin Rearrangement Coincides with Activation of Human Papillomavirus Type 31 Late Gene Expression. J. Virol.
75: 10005-10013
[Abstract]
[Full Text]
-
Vance, K. W., Campo, M. S., Morgan, I. M.
(2001). A Novel Silencer Element in the Bovine Papillomavirus Type 4 Promoter Represses the Transcriptional Response to Papillomavirus E2 Protein. J. Virol.
75: 2829-2838
[Abstract]
[Full Text]
-
Su, G. H., Sohn, T. A., Ryu, B., Kern, S. E.
(2000). A Novel Histone Deacetylase Inhibitor Identified by High-Throughput Transcriptional Screening of a Compound Library. Cancer Res.
60: 3137-3142
[Abstract]
[Full Text]
-
Stünkel, W., Huang, Z., Tan, S.-H., O'Connor, M. J., Bernard, H.-U.
(2000). Nuclear Matrix Attachment Regions of Human Papillomavirus Type 16 Repress or Activate the E6 Promoter, Depending on the Physical State of the Viral DNA. J. Virol.
74: 2489-2501
[Abstract]
[Full Text]